article thumbnail

Preserving Patient Access to Compounded Medications Act of 2017

Pharmacy Times

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.

article thumbnail

Key vaccine adjuvant biosynthesised

European Pharmaceutical Review

highlighted in the paper a key milestone achieved by the vaccine industry in 2017: “the first saponin adjuvant AS01 was approved for use in a human vaccine, the highly effective shingles vaccine Shingrix (produced by GSK).” “Our Martin et al. Our study opens unprecedented opportunities for bioengineering vaccine adjuvants.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rapid microbiology testing market growth expected 2022 to 2027

European Pharmaceutical Review

A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 The research includes historic market data from 2017 to 2021, using 2022 as the base year. million in 2017 and continued to grow until 2021. percent between 2022 and 2027.

article thumbnail

GSK partners LifeMine on fungi-derived medicines

pharmaphorum

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. Greg Verdine – LifeMine.

article thumbnail

Rite Aid’s Closing and Bankruptcy: The Full Story!

The Happy PharmD

However, efforts to merge with Walgreens in 2017 and later with Albertsons in 2018 failed, leaving Rite Aid struggling to redefine its place in a competitive market. Compounding its challenges, Rite Aid became entangled in legal issues, notably linked to the opioid crisis.

article thumbnail

Teijin and Axcelead sign deal for drug discovery research JV

Pharmaceutical Technology

In addition to supporting drug discovery research, the new company will investigate and acquire candidate compounds for new drugs. It operates as the core company of the Axcelead group that took over Takeda Pharmaceutical Company’s drug discovery platform business in 2017.

article thumbnail

Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health

pharmaphorum

Legislation is already in place allowing companies to grow the plant for medicinal purposes under license, doctors have been able to prescribe it since 2017 with full reimbursement from health insurers.